Topical Apraclonidine Lessens Pain After Intravitreal Therapy

Topical apraclonidine before intravitreal injection reduced pain, but may not decrease the risk for subconjunctival hemorrhage in all patients, a new study has found.
Medscape Medical News

Full Story →